REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector. read more
REGENXBIO Interviews Employee Reviews
All
Positive
Constructive
What did you like most about the interview process?
It was fast compared to the other companies. In retrospect, speed could be because of turnover.
Very smooth, just took a bit to negotiate contract because it was the first field employee
What would you improve about your company's interview process?
There aren't any Interviews reviews of REGENXBIO yet.
Be the first to contribute a review.
×